ArticleScientific reports2026
Emergence of human enteric adenovirus F41 among children with gastroenteritis in North-central Bangladesh, 2022-2024.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human adenovirus F-41 (HAdV-F41) is an emerging cause of pediatric gastroenteritis, but data from South Asia remain limited. We investigated the molecular epidemiology, clinical features, seasonality of adenovirus-associated gastroenteritis and feasibility of an immunochromatography (IC) kit among children under 5 in north-central Bangladesh during July 2022-June 2024. Fecal samples from 360 children with acute gastroenteritis were tested for viral and bacterial pathogens using PCR, sequencing, and phylogenetic analyses. HAdV was detected in 7% (25/360) of cases, which was the second most common virus after rotavirus. Most adenovirus-positive samples (76%, 19/25) were adenovirus F-41. Infected children, aged 12-35 months, exhibited more severe gastrointestinal symptoms, including dehydration and severe vomiting. Infections peaked during colder months and were correlated with temperature. Study strains were closely related with contemporary global adenovirus F-41 strains. A rapid immunochromatographic assay for HAdV demonstrated high agreement with PCR. These findings identify adenovirus F-41 as an emerging contributor to pediatric gastroenteritis in Bangladesh and highlight the need for enhanced surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.